Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents
Guangdi Wang
Topics & Concepts
FulvestrantAntiestrogenEstrogen receptorMedicinePharmacologyTamoxifenOncologyInternal medicineCancerBreast cancerEstrogen and related hormone effectsComputational Drug Discovery MethodsReceptor Mechanisms and Signaling